An observational study in Urinary Infection, sponsored by University Hospital, Caen. Status unknown at 1 site in France. Open to participants aged Up to 16 Years. Per ClinicalTrials.gov, last updated 2018-01-17.
Sponsored by University Hospital, Caen · Observational
Cystography is a frequent pediatric examination, although indications have been recently restricted .
Current indications in our center are:
However, no recent study has investigated the prevalence of urinary tract infections post cystography.
There is no recent epidemiological data on this risk of infection, especially since the management of infections has changed and aseptic precautions during retrograde cystography have evolved with most of the time coverage. antibiotic.
The main objective of this multi-center epidemiological prospective study is to perform a recent analysis of the retrograde post-cystographic urinary tract infection rate.
Material and methods:
Epidemiological, observational, multicenter, prospective study over a period from January 2018 to January 2019. No therapeutic modification will be undertaken at the end of the study.
Parents will be called one months after the exam to check if their child had a urinary infection.
Cystography is a frequent examination, performed in the context of acute pyelonephritis.
However, its realization has decreased significantly, in particular because of the invasive aspect and urinary infections identified retrospectively. (1) (2) (3) (4)
The only indications to the University Hospital of Caen are:
There are 2 techniques for performing cystography:
Urinary tract infections during the month following cystography are considered secondary to cystography. (7) They are estimated at 6% in old studies (7) However, there is no recent study on the prevalence of urinary tract infections after cystography (article (7): 6%: Complications of voiding cystourethrography in the evaluation of infants with prenatally detected hydronephrosis, The Journal of Urology, 162, 1221-1223, september 1999)
The main objective of our study is therefore to have recent data on the rate of retrograde post cystographic urinary tract infections in the month following the examination.
The secondary objectives are to analyze the rate of urinary tract infections according to age, sex, indications, and circumstances.
Material and method:
Epidemiological, observational, multicenter, prospective study over a period from January 2018 to January 2019. No therapeutic modification will be undertaken at the end of the study.
Included patients are all children under 16 years of age with retrograde cystography and excluded patients are children over 16 years old and those with ongoing infection.
During the realization of the cystography the information required for the study will be noted, namely:
Clear, fair, and appropriate information about the study is then given to the parents.
They are informed, that with their authorization, they will receive a call to a month of the cystography to know if their child presented a urinary infection (fever, BU and ECBU positive) after the gestexamure.
Their written consent is collected. The data collected after the telephone passages are listed in a table and will be analyzed at the end of the study.
all patients under the age of 16 who have had retrograde cystograph
Exclusion Criteria:
all children less than 16 years having cystography
Diagnostic Test: cystography
observationnal study
recent analysis of urinary post cystography infection rate in the pediatric population
fievre, urine test strip, CBEU
Time frame: 1 month
infection rate epidemiology
age, sexe; indication of the test
Time frame: 1 month
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Jan 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Caen